Arena Gains Evidence To Address FDA Concerns About Lorcaserin, But More Still Needed
This article was originally published in The Pink Sheet Daily
Executive Summary
The biotech released some new results regarding the safety of lorcaserin as it continues to pursue FDA approval for the drug.